| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 08/06/2008 | CN101236158A Reticular cell detection method and detection device |
| 08/06/2008 | CN101235031A Oriented synthesis and crystal structure of 21(S) argatroban, and preparation for monohydrate thereof |
| 08/06/2008 | CN101235030A 1-substituted-5-trifluoromethyl-2-(1H)pyridone compound, preparation method and use thereof |
| 08/06/2008 | CN100408574C Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides |
| 08/06/2008 | CN100408573C Pyrazole compounds useful as protein kinase inhibitors |
| 08/06/2008 | CN100408572C Imidazole derivatives as glutmate receptor antagonists |
| 08/06/2008 | CN100408565C Pesticidal 1-ayl-3-amidoxime-pyrazole derivatives |
| 08/06/2008 | CN100408564C Pyrazole derivatives for treating HIV |
| 08/06/2008 | CN100408099C Oral pharmaceutical composition containing a block copolymer |
| 08/05/2008 | US7408076 2-Bromoanaline and 2-chloroaniline compounds |
| 08/05/2008 | US7408067 Neuregulins such as 4-(4-Hydroxyphenylthio)-piperidine trifluoroacetate for treatment of dysfunctions of central and autonomic nervous systems |
| 08/05/2008 | US7408066 1-(1-Heteroarylmethyl)piperidin-4-ylcarbonyl)-4-substituted-piperidine derivatives; respiratory allergies, congestion, obesity, metabolic syndrome nonalcoholic fatty liver disease, hepatic steatosis, nonalcoholic steatohepatitis, cirrhosis, hepatacellular carcinoma or cognition deficit disorders |
| 08/05/2008 | US7408065 P2X7 receptor antagonists and their use |
| 08/05/2008 | US7407976 Thiazoles and oxazoles useful as modulators of ATP-Binding Cassette transporters |
| 08/05/2008 | US7407974 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 08/05/2008 | US7407972 e.g. 4,5-Dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 5-[(3-fluoro-2'-methanesulfonyl-biphenyl-4-yl)-amide]; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 08/05/2008 | US7407971 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 08/05/2008 | US7407969 e.g. N-[1-(2-aminoethyl)-4-piperidinyl]-7-methyl-3-(8-quinolinylmethyl)-3H-imidazo[4,5-b]pyridin-2-amine tetrahydrochloride trihydrate; immunostimulant; lower respiratory tract illness during infancy and childhood, asthma, pneumonia |
| 08/05/2008 | US7407968 Compounds |
| 08/05/2008 | US7407963 Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof |
| 08/05/2008 | US7407962 Heteroaryl compounds useful as inhibitors or protein kinases |
| 08/05/2008 | US7407961 Adenosine antagonists; depression, dementia (e.g. Alzheimer's disease), Parkinson's disease, anxiety, pain, cerebrovascular disorders, heart failure, hypertension, edema, obesity, bronchial asthma |
| 08/05/2008 | US7407958 2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors |
| 08/05/2008 | US7407956 Benzamide inhibitors of the P2X7 receptor |
| 08/05/2008 | US7407950 N-(heteroaryl)-1H-indole-2-carboxamide derivatives and their use as vanilloid TRPV1 receptor ligands |
| 08/05/2008 | CA2423820C New indoline derivatives, the process for preparing them and the pharmaceutical compounds that contain them |
| 08/05/2008 | CA2417081C New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |
| 08/05/2008 | CA2404152C Inhibition of cyclooxygenase-2 activity |
| 08/05/2008 | CA2293549C Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase |
| 08/05/2008 | CA2293358C Tricyclic sulfonamide inhibitors of farnesyl-protein transferase |
| 08/05/2008 | CA2268450C Neurotrophin antagonist compositions |
| 08/05/2008 | CA2226184C A process for the optical purification of enantiomerically enriched benzimidazole derivatives |
| 08/05/2008 | CA2224435C Pyrrolopyrimidines and processes for the preparation thereof |
| 08/05/2008 | CA2176649C 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones |
| 08/05/2008 | CA2153984C Process for the manufacture of a tricyclic compound |
| 07/31/2008 | WO2008091901A1 Heterodimers and methods of using them |
| 07/31/2008 | WO2008091752A2 Quinolone carboxylic acids, derivatives thereof, processes for their preparation and their use as antibacterial agents |
| 07/31/2008 | WO2008091580A2 Fungicidal amides |
| 07/31/2008 | WO2008090757A1 Squarylium compound, squarylium compound-containing composition, optical filter and front filter for display |
| 07/31/2008 | WO2008090434A1 Substituted n-bicyclicalkyl bicyclic carboxyamide compounds |
| 07/31/2008 | WO2008090357A2 N, n; -substituted piperazines binding to melanocortin receptor |
| 07/31/2008 | WO2008090140A1 Aryloxypropanolamines, methods of preparation thereof and use of aryloxypropanolamines as medicaments |
| 07/31/2008 | WO2008089580A1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 07/31/2008 | WO2008073687A3 Compounds and compositions as protein kinase inhibitors |
| 07/31/2008 | WO2008071587A3 2-(piperidin-4-yl)-4-phenoxy- or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors |
| 07/31/2008 | WO2008071587A2 2-(piperidin-4-yl)-4-phenoxy- or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors |
| 07/31/2008 | WO2008070306A3 1,5-diphenyl-3-benzylamin0-1,5-dihydr0pyrr0lidin-2-0ne as cb1 receptor modulators |
| 07/31/2008 | WO2008070306A2 1,5-diphenyl-3-benzylamin0-1,5-dihydr0pyrr0lidin-2-0ne as cb1 receptor modulators |
| 07/31/2008 | WO2008068767A3 A novel crystalline form of lansoprazole |
| 07/31/2008 | WO2008068507A3 2 -phenylamino, 6- (pyrid-3-yl) quinazoline derivatives as raf-protein kinase inhibitors in cancer treatment |
| 07/31/2008 | WO2008068423A3 P<0}{0pyrrol derivatives, preparation and use of the same in therapy<0} |
| 07/31/2008 | WO2008063232A3 Substituted pyrazolopyrimidines |
| 07/31/2008 | WO2008062424A3 Substituted 4,5-dihydro-1h-pyrazole derivatives as cannabinoid modulators |
| 07/31/2008 | WO2008061236A3 Sulfoximines as kinase inhibitors |
| 07/31/2008 | WO2008011557A3 Heteroaryl inhibitors of rho kinase |
| 07/31/2008 | WO2008008493A8 Alkyne-substituted pyridone compounds and methods of use |
| 07/31/2008 | WO2007077201A9 Piperazine compounds with a herbicidal action |
| 07/31/2008 | US20080182988 Reaction product of aripiprazole with methanol |
| 07/31/2008 | US20080182987 Method For Producing 2-(4-Methyl-2-Phenylpiperazine-1-Yl)-3-Cyanopiridine |
| 07/31/2008 | US20080182881 TNF-alpha production inhibitors |
| 07/31/2008 | US20080182877 Rimonabant forms and methods of making the same |
| 07/31/2008 | US20080182874 e.g. 1-[6-Chloro-5-[(tricyclo[3.3.1.13,7]dec-1-ylacetyl)amino]-2-quinolinyl]-4piperidinecarboxylic acid; adamantyl-containing purinergic receptor P2X7 antagonists; antiinflammatory agent, immune or cardiovascular diseases; asthma, chronic obstructive pulmonary disease, rheumatoid arthritis |
| 07/31/2008 | US20080182860 Pyrimidine Compounds as Purine Receptor Antagonist |
| 07/31/2008 | US20080182857 Heat Shock Protein 90 inhibitors; 5-(2,4-dihydroxyphenyl)-4-(naphth-1-yl)-4H-1,2,4-triazole-3-thiol; incorrect protein folding or aggregation; hydrazonederivatives react with dimiadazole cabonyl/thiocarbonyl derivatives; hydrazines derivatives react with isocyanate or isothiocyanates; tumors, cancer |
| 07/31/2008 | US20080182856 Novel crystalline forms of aripiprazole |
| 07/31/2008 | US20080182855 Antibacterial Quinoline Derivatives |
| 07/31/2008 | US20080182854 4-Amino-5-Cyanopyrimidine Derivatives |
| 07/31/2008 | US20080182851 Acetylene derivatives as stearoyl coa desaturase inhibitors |
| 07/31/2008 | US20080182850 3-(heteroaryl)alanine derivatives-inhibitors of leukocyte adhesion mediated by vla-4 |
| 07/31/2008 | US20080182840 Inhibitors of the FAK (focal adhesion kinase) protein tyrosine kinases, antiproliferative, antitumor; for example 5-{4-[(1-Hydroxy-cyclopentylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one |
| 07/31/2008 | US20080182839 LFA1 related immune and/or inflammatory disorders; interactions with leukointegrins; such as fused nitrogen heterocyclic secondary amine derivatives |
| 07/31/2008 | US20080182750 Cyano Anthranilamide Insecticides |
| 07/31/2008 | US20080182302 Open reading frames which encode polypeptides sufficient to direct the biosynthesis synthesis of a safracin molecule having improved properties and that could be used in the hemi-synthesis of new ecteinascidins compounds; combinatorial chemistry; antitumor agents; broad-spectrum antibiotics; bactericides |
| 07/31/2008 | US20080181866 treating hepatitis C virus infections; 2-[4-(4-Cyclopropylcarbamoyl-phenyl)-thiazol-2-ylcarbamoyl]-indole-1-carboxylic acid benzyl ester; inhibiting viral and host cell targets in the replication cycle |
| 07/31/2008 | DE102007010815B3 New N-phenylsulfonyl-3-amidino-phenylalanine piperidide derivatives useful as antitumor agents |
| 07/31/2008 | CA2790690A1 Quinoline carboxylic acids, derivatives thereof, and methods of making and using same |
| 07/31/2008 | CA2676199A1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 07/31/2008 | CA2662614A1 Development and characterization of novel proton conducting aromatic polyether type copolymers bearing main and side chain pyridine groups |
| 07/30/2008 | EP1950255A1 Cation compound, dye compound and use thereof, and optical information recording medium |
| 07/30/2008 | EP1950211A1 Process for production of cinnamamide derivative |
| 07/30/2008 | EP1950201A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 07/30/2008 | EP1950199A1 Proline derivatives and use thereof as drugs |
| 07/30/2008 | EP1949896A2 Linear dicationic terphenyls and their aza analogues as antiparasitic agents |
| 07/30/2008 | EP1948649A2 Fungicidal carboxamides |
| 07/30/2008 | EP1948640A2 Triazine compounds comprising substituents containing amino groups and carboxyl groups |
| 07/30/2008 | EP1948639A2 Novel carbocyclic fused cyclic amines |
| 07/30/2008 | EP1948638A1 Compounds for the treatment of inflammatory disorders |
| 07/30/2008 | EP1948637A1 Process for amorphous esomeprazole |
| 07/30/2008 | EP1948636A2 Compounds and compositions as lxr modulators |
| 07/30/2008 | EP1948635A1 Benzimidazole derivatives as gyrase inhibitors |
| 07/30/2008 | EP1948617A2 Pyrimidinones as casein kinase ii (ck2) modulators |
| 07/30/2008 | EP1948616A1 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the trpv1 receptor |
| 07/30/2008 | EP1948615A2 Compounds useful in therapy |
| 07/30/2008 | EP1948605A2 Modulators of the h3 receptor useful for the treatment of disorders related thereto |
| 07/30/2008 | EP1948603A1 Tetrahydroindole derivatives for treatment of alzheimer's disease |
| 07/30/2008 | EP1948597A1 Derivatives for modulation of ion channels |
| 07/30/2008 | EP1948193A2 Aminopyrimidines useful as kinase inhibitors |
| 07/30/2008 | EP1948187A2 Chemical compounds |
| 07/30/2008 | EP1948168A2 Compositions and treatments for inhibiting kinase and/or hmg-coa reductase |
| 07/30/2008 | EP1747204B1 Tri-substituted ureas as cytokine inhibitors |